| Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy O De Filippo, F D’Ascenzo, F Angelini, PP Bocchino, F Conrotto, ... New England Journal of Medicine 383 (1), 88-89, 2020 | 1124 | 2020 |
| Five-year outcomes with PCI guided by fractional flow reserve P Xaplanteris, S Fournier, NHJ Pijls, WF Fearon, E Barbato, PAL Tonino, ... New England Journal of Medicine 379 (3), 250-259, 2018 | 821 | 2018 |
| Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ... Circulation 125 (16), 2015-2026, 2012 | 815 | 2012 |
| Short physical performance battery and all-cause mortality: systematic review and meta-analysis R Pavasini, J Guralnik, JC Brown, M di Bari, M Cesari, F Landi, B Vaes, ... BMC medicine 14, 1-9, 2016 | 759 | 2016 |
| Complete revascularization with multivessel PCI for myocardial infarction SR Mehta, DA Wood, RF Storey, R Mehran, KR Bainey, H Nguyen, ... New England Journal of Medicine 381 (15), 1411-1421, 2019 | 697 | 2019 |
| Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised … P Vranckx, M Valgimigli, L Eckardt, J Tijssen, T Lewalter, G Gargiulo, ... The Lancet 394 (10206), 1335-1343, 2019 | 604 | 2019 |
| Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year … PW Serruys, B Chevalier, Y Sotomi, A Cequier, D Carrié, JJ Piek, ... The Lancet 388 (10059), 2479-2491, 2016 | 588 | 2016 |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: relationship with gene polymorphisms and … G Campo, G Parrinello, P Ferraresi, B Lunghi, M Tebaldi, M Miccoli, ... Journal of the American College of Cardiology 57 (25), 2474-2483, 2011 | 414 | 2011 |
| Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial M Valgimigli, G Percoco, P Malagutti, G Campo, F Ferrari, D Barbieri, ... Jama 293 (17), 2109-2117, 2005 | 412 | 2005 |
| Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the … M Valgimigli, G Campo, G Percoco, L Bolognese, C Vassanelli, ... Jama 299 (15), 1788-1799, 2008 | 348 | 2008 |
| Diagnostic performance of in‐procedure angiography‐derived quantitative flow reserve compared to pressure‐derived fractional flow reserve: the FAVOR II Europe‐Japan study J Westra, BK Andersen, G Campo, H Matsuo, L Koltowski, A Eftekhari, ... Journal of the American Heart Association 7 (14), e009603, 2018 | 319 | 2018 |
| Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates M Valgimigli, A Patialiakas, A Thury, E McFadden, S Colangelo, G Campo, ... Journal of the American College of Cardiology 65 (8), 805-815, 2015 | 301 | 2015 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 272 | 2018 |
| Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double … M Valgimigli, G Campo, N de Cesare, E Meliga, P Vranckx, A Furgieri, ... Circulation 119 (25), 3215-3222, 2009 | 272* | 2009 |
| Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury G Morciano, C Giorgi, M Bonora, S Punzetti, R Pavasini, MR Wieckowski, ... Journal of molecular and cellular cardiology 78, 142-153, 2015 | 259 | 2015 |
| Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a … M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra, ... The Lancet 387 (10016), 357-366, 2016 | 240 | 2016 |
| Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary … S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ... JACC: Cardiovascular Interventions 4 (1), 66-75, 2011 | 216 | 2011 |
| Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C‐ring conformation M Bonora, C Morganti, G Morciano, G Pedriali, ... EMBO reports 18 (7), 1077-1089, 2017 | 197 | 2017 |
| Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction … M Valgimigli, M Tebaldi, G Campo, S Gambetti, L Bristot, M Monti, ... JACC: Cardiovascular Interventions 5 (3), 268-277, 2012 | 196 | 2012 |
| Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets F D'Ascenzo, O De Filippo, G Gallone, G Mittone, MA Deriu, ... The Lancet 397 (10270), 199-207, 2021 | 190 | 2021 |
Simone BiscagliaInterventional Cardiologist @ Azienda Ospedaliera-UniversitariaVerified email at unife.it
